Literature DB >> 8530825

Hyperlipidemia in acute pancreatitis. Cause or epiphenomenon?

J E Domínguez-Muñoz1, F Jünemann, P Malfertheiner.   

Abstract

Whether hyperlipidemia is a pre-existing metabolic disorder or a consequence of acute pancreatitis is still debated. Mild to moderate elevation of serum triglyceride levels are likely to be an epiphenomenon of the pancreatic disease. A marked hyperchylomicronemia and hypertrygliceridemia would be needed to trigger acute pancreatitis; a relevant defect in the lipid catabolism and clearance should therefore pre-exist. The aim of the present study was to investigate whether patients with acute pancreatitis and marked hyperlipidemia have an impaired clearance capacity of exogenous lipids, which would define the hyperlipidemia as a preexistent abnormality and therefore a potential cause of the pancreatic disease. With this aim, the kinetics of the removal of exogenous triglycerides from the circulation have been analyzed. Twenty patients with acute pancreatitis have been studied. Ten of them suffered from an episode of acute pancreatitis with marked hyperlipidemia (serum triglyceride levels > 20 mmol/L). Four to six months after recovery from the pancreatitis, a two-stage infusion of Intralipid 20% was carried out and the fractional removal rate (K2) and the maximal clearance capacity (K1) of exogenous triglycerides were calculated. At low infusion rates a first order kinetics for removal was observed, whereas at high infusion rates a zero order kinetics was operating. All patients with a previous attack of normolipidemic acute pancreatitis had normal K2 and K1 values. Five patients with previous hyperlipidemic acute pancreatitis had an abnormally low clearance capacity of exogenous triglycerides, whereas the remaining five had normal removal values. The present study provides new information in the association between hyperlipidemia and acute pancreatitis by showing that even a marked elevation of serum lipid levels should not be invariably considered as the etiological factor of the pancreatic disease, even if other potential causes are not evident.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8530825     DOI: 10.1007/BF02785883

Source DB:  PubMed          Journal:  Int J Pancreatol        ISSN: 0169-4197


  24 in total

1.  Experimental pancreatitis and plasma lipids.

Authors:  C WANG; L STRAUSS; D ADLERSBERG
Journal:  Gastroenterology       Date:  1958-11       Impact factor: 22.682

2.  Clinical and metabolic study of alcoholic hyperlipidaemia.

Authors:  A Chait; M Mancini; A W February; B Lewis
Journal:  Lancet       Date:  1972-07-08       Impact factor: 79.321

3.  Estrogen-induced pancreatitis in patients with previously covert familial type V hyperlipoproteinemia.

Authors:  C J Glueck; D Scheel; J Fishback; P Steiner
Journal:  Metabolism       Date:  1972-07       Impact factor: 8.694

4.  Hyperlipemia in acute pancreatitis. Metabolic studies in a patient and demonstration of abnormal lipoprotein-triglyceride complexes resistant to the action of lipoprotein lipase.

Authors:  J I Kessler; M Miller; D Barza; S Mishkin
Journal:  Am J Med       Date:  1967-06       Impact factor: 4.965

5.  Blood volume measurement: a critical study prediction of normal values: controlled measurement of sequential changes: choice of a bedside method.

Authors:  F J Dagher; J H Lyons; D C Finlayson; J Shamsai; F D Moore
Journal:  Adv Surg       Date:  1965

6.  Relationships of lipoprotein lipase and hyperlipemia in pancreatitis.

Authors:  K L Stackhouse; D D Glass; B Zimmermann
Journal:  Surg Forum       Date:  1966

7.  Hyperlipidemia in acute pancreatitis. Relationship with etiology, onset, and severity of the disease.

Authors:  J E Dominguez-Muñoz; P Malfertheiner; H H Ditschuneit; J Blanco-Chavez; W Uhl; M Büchler; H Ditschuneit
Journal:  Int J Pancreatol       Date:  1991 Nov-Dec

8.  Catabolism of chylomicron remnants in patients with previous acute pancreatitis.

Authors:  A Rollán; S Guzmán; F Pimentel; F Nervi
Journal:  Gastroenterology       Date:  1990-06       Impact factor: 22.682

9.  Impaired lipid clearance in patients with previous acute pancreatitis.

Authors:  S Guzmán; F Nervi; O Llanos; P León; V Valdivieso
Journal:  Gut       Date:  1985-09       Impact factor: 23.059

10.  Lipid intolerance does not account for susceptibility to alcoholic and gallstone pancreatitis.

Authors:  P S Haber; J S Wilson; M V Apte; W Hall; K Goumas; R C Pirola
Journal:  Gastroenterology       Date:  1994-03       Impact factor: 22.682

View more
  11 in total

Review 1.  Acute pancreatitis after single-dose exposure to propofol: a case report and review of literature.

Authors:  Qaiser Jawaid; Michael E Presti; Brent A Neuschwander-Tetri; Frank R Burton
Journal:  Dig Dis Sci       Date:  2002-03       Impact factor: 3.199

Review 2.  Hypertriglyceridemia-induced pancreatitis: A case-based review.

Authors:  S-Ian Gan; Alun-L Edwards; Christopher-J Symonds; Paul-L Beck
Journal:  World J Gastroenterol       Date:  2006-11-28       Impact factor: 5.742

3.  Elevated serum triglycerides are independently associated with persistent organ failure in acute pancreatitis.

Authors:  Haq Nawaz; Efstratios Koutroumpakis; Jeffrey Easler; Adam Slivka; David C Whitcomb; Vijay P Singh; Dhiraj Yadav; Georgios I Papachristou
Journal:  Am J Gastroenterol       Date:  2015-09-01       Impact factor: 10.864

4.  Effect of admission hypertriglyceridemia on the episodes of severe acute pancreatitis.

Authors:  Li-Hui Deng; Ping Xue; Qing Xia; Xiao-Nan Yang; Mei-Hua Wan
Journal:  World J Gastroenterol       Date:  2008-07-28       Impact factor: 5.742

Review 5.  Hypertriglyceridemic pancreatitis: Epidemiology, pathophysiology and clinical management.

Authors:  Nicolò de Pretis; Antonio Amodio; Luca Frulloni
Journal:  United European Gastroenterol J       Date:  2018-01-22       Impact factor: 4.623

Review 6.  Recurrent acute pancreatitis in a patient with type IIb hyperlipoproteinemia: a case report and review of the literature in Korea.

Authors:  Byung Kook Kim; Mi Jin Kim; Won Chul Chang; Kwang Ha Yoo; Young Goo Shin; Choon Hee Chung
Journal:  Yonsei Med J       Date:  2006-02-28       Impact factor: 2.759

Review 7.  Relationships between Metabolic Comorbidities and Occurrence, Severity, and Outcomes in Patients with Acute Pancreatitis: A Narrative Review.

Authors:  Xu Li; Xiaolin Guo; Huifan Ji; Junqi Niu; Pujun Gao
Journal:  Biomed Res Int       Date:  2019-10-07       Impact factor: 3.411

8.  Incidence and Management of Hypertriglyceridemia-Associated Acute Pancreatitis: A Prospective Case Series in a Single Australian Tertiary Centre.

Authors:  Hong Lin Evelyn Tan; Georgina McDonald; Alexander Payne; William Yu; Zahrul Ismadi; Huy Tran; Jon Gani; Katie Wynne
Journal:  J Clin Med       Date:  2020-12-06       Impact factor: 4.241

Review 9.  Causes, clinical findings and therapeutic options in chylomicronemia syndrome, a special form of hypertriglyceridemia.

Authors:  György Paragh; Ákos Németh; Mariann Harangi; Maciej Banach; Péter Fülöp
Journal:  Lipids Health Dis       Date:  2022-02-10       Impact factor: 3.876

10.  High-volume hemofiltration plus hemoperfusion for hyperlipidemic severe acute pancreatitis: a controlled pilot study.

Authors:  Shiren Sun; Lijie He; Ming Bai; Hongbao Liu; Yangping Li; Li Li; Yan Yu; Meilan Shou; Rui Jing; Liyuan Zhao; Chen Huang; Hanmin Wang
Journal:  Ann Saudi Med       Date:  2015 Sep-Oct       Impact factor: 1.526

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.